IRIS
AMATO, FELICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.816
AS - Asia 3.775
NA - Nord America 3.334
SA - Sud America 505
Continente sconosciuto - Info sul continente non disponibili 242
AF - Africa 96
OC - Oceania 16
Totale 11.784
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.176
SG - Singapore 1.605
IT - Italia 1.589
RU - Federazione Russa 1.197
VN - Vietnam 774
CN - Cina 734
BR - Brasile 421
FR - Francia 264
HK - Hong Kong 246
NL - Olanda 154
DE - Germania 150
GB - Regno Unito 100
FI - Finlandia 91
BD - Bangladesh 81
CA - Canada 76
JP - Giappone 71
IN - India 63
IE - Irlanda 58
MX - Messico 47
AR - Argentina 36
IQ - Iraq 32
PL - Polonia 31
CI - Costa d'Avorio 30
KR - Corea 29
SE - Svezia 24
AT - Austria 23
ES - Italia 23
ZA - Sudafrica 23
UA - Ucraina 21
PH - Filippine 20
HU - Ungheria 18
LT - Lituania 16
ID - Indonesia 15
AU - Australia 14
EC - Ecuador 14
TR - Turchia 13
CO - Colombia 12
TH - Thailandia 12
PK - Pakistan 11
BE - Belgio 9
MA - Marocco 9
VE - Venezuela 9
SA - Arabia Saudita 8
MT - Malta 7
TW - Taiwan 7
CR - Costa Rica 6
CZ - Repubblica Ceca 6
DK - Danimarca 6
IL - Israele 6
IR - Iran 6
JO - Giordania 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
HN - Honduras 5
TN - Tunisia 5
AZ - Azerbaigian 4
EG - Egitto 4
LU - Lussemburgo 4
BY - Bielorussia 3
ET - Etiopia 3
GR - Grecia 3
JM - Giamaica 3
LB - Libano 3
LY - Libia 3
MK - Macedonia 3
NP - Nepal 3
PE - Perù 3
PR - Porto Rico 3
PS - Palestinian Territory 3
PY - Paraguay 3
SV - El Salvador 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BS - Bahamas 2
CH - Svizzera 2
CL - Cile 2
DO - Repubblica Dominicana 2
EE - Estonia 2
KE - Kenya 2
KG - Kirghizistan 2
LV - Lettonia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
BZ - Belize 1
CG - Congo 1
CM - Camerun 1
CV - Capo Verde 1
GE - Georgia 1
GM - Gambi 1
Totale 11.521
Salva come PNG Salva come JPEG
Città #
Singapore 765
San Jose 430
Ashburn 315
Moscow 283
Chandler 267
Naples 247
Hong Kong 233
Beijing 225
Napoli 210
Ho Chi Minh City 190
Hanoi 155
Santa Clara 129
Amsterdam 124
Hefei 104
Los Angeles 89
Lauterbourg 86
The Dalles 84
Dong Ket 74
Tokyo 66
Millbury 65
New York 61
Milan 54
Boston 53
Rome 52
São Paulo 50
Des Moines 49
Munich 49
Princeton 45
Council Bluffs 44
Buffalo 41
Nanjing 39
Da Nang 36
Redondo Beach 32
Houston 31
Lawrence 30
Chicago 28
Orem 27
Dallas 26
Brooklyn 25
Haiphong 25
Turku 24
Warsaw 24
Montreal 23
Atlanta 22
Denver 22
Seattle 22
Wilmington 22
Mexico City 21
Nuremberg 21
Ottawa 20
Seoul 20
Tampa 20
Frankfurt am Main 19
Phoenix 19
Stockholm 19
Manchester 18
Helsinki 16
Ottaviano 16
Poplar 16
Ercolano 15
Can Tho 14
Lappeenranta 14
London 14
Abbiategrasso 13
Baghdad 13
Bologna 13
Hải Dương 12
Johannesburg 12
Toronto 12
Boardman 11
Charlotte 11
Formia 11
Washington 11
Biên Hòa 10
Brasília 10
Budapest 10
Nanchang 10
Ninh Bình 10
Redwood City 10
Rio de Janeiro 10
San Francisco 10
Sydney 10
Chennai 9
Dhaka 9
Hebei 9
Jiaxing 9
Vienna 9
Afragola 8
Bari 8
Falkenstein 8
Hangzhou 8
Marsala 8
Mumbai 8
Nocera Inferiore 8
Palermo 8
Pavia 8
Salvador 8
Shenyang 8
Tianjin 8
Turin 8
Totale 5.737
Salva come PNG Salva come JPEG
Nome #
Analisi qualitativa e quantitativa di splicing alternativi mediante una singola reazione di droplet digital PCR 518
MicroRNA come target terapeutici per il trattamento della fibrosi cistica 249
3D Chitosan-Gallic Acid Complexes: Assessment of the Chemical and Biological Properties 204
Corrigendum: Gut Microbiota Features in Young Children With Autism Spectrum Disorders 202
CFTR expression during cellular senescence 201
Economical, legal and ethical considerations on reevaluation and retesting in molecular diagnostics 198
Clinical implication of cellular senescence on CFTR expression. 187
Gut Microbiota Features in Young Children with Autism Spectrum Disorders. [*Coretti L. corresponding author] 187
Enhanced frequency of CFTR gene variants in couples who are candidates for assisted reproductive technology treatment. 184
Olfactory performance in Cystic Fibrosis patients 184
Comprehensive Molecular Analysis of Disease-Related Genes as First-Tier Test for Early Diagnosis, Classification, and Management of Patients Affected by Nonsyndromic Ichthyosis 168
Peptide Nucleic Acids as miRNA Target Protectors for the Treatment of Cystic Fibrosis 162
Qualitative and quantitative evaluation of alternative splicing products using the digital droplet PCR 160
Epigenetica, diagnostica e terapia della fibrosi cistica 159
Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles 158
Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract 157
An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis 156
Cystic Fibrosis: The Sense of Smell 156
Cystic Fibrosis: the sense of smell. 156
Assisting PNA transport through cystic fibrosis human airway epithelia with biodegradable hybrid lipid-polymer nanoparticles 156
Tropomyosin-related kinase B receptor polymorphisms and isoforms expression in suicide victims 150
Comparative Evaluation of Nasal and Small Intestine Expression of ACE2, TMPRSS2 and ACE1 and in Children and in Adults 149
Insights into Porphyromonas somerae in Bladder Cancer Patients: Urinary Detection by ddPCR 148
Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization 148
Letter to the Editor: Is there an Indication for Testing the Methylenetetrahydrofolate reductase A1298C Variant in Routine Clinical Settings? 146
The MBL2 genotype relates to COVID-19 severity and may help to select the optimal therapy 145
Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression 145
A Novel DHPLC-Based Procedure for the Analysis of COL1A1 and COL1A2 Mutations in Osteogenesis Imperfecta. 143
CONVERSIONE GENICA FRA I GENI CODIFICANTI IL TRIPSINOGENO PRSS1 E PRSS2: UN EVENTO RICOMBINANTE RARO IN DUE PAZIENTI PEDIATRICI. 142
SARS-CoV-2 Subgenomic N (sgN) Transcripts in Oro-Nasopharyngeal Swabs Correlate with the Highest Viral Load, as Evaluated by Five Different Molecular Methods 141
Genetic Diseases That Predispose to Early Liver Cirrhosis 140
ACE2: The Major Cell Entry Receptor for SARS-CoV-2 139
Design, synthesis and biochemical investigation, by in vitro luciferase reporter system, of peptide nucleic acids as new inhibitors of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression 138
Extensive molecular analysis of patients bearing CFTR-related disorders. 137
Serum Galectin-3 and Aldosterone: potential biomarkers of cardiac complications in patients with COVID-19 135
Interactions of spike‐rbd of sars‐cov‐2 and platelet factor 4: New insights in the etiopathogenesis of thrombosis 134
Identification of an ultra-rare Alu insertion in the CFTR gene: Pitfalls and challenges in genetic test interpretation 133
Natural phenylalanine hydroxylase variants that confer a mild phenotype affect the enzyme's conformational stability and oligomerization equilibrium 133
Butyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells 133
Valutazione degli effetti del butirrato sulla fisiologia intestinale mediante real-time PCR. 131
L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fibrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients 130
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 129
The role of functional studies in the diagnosis and treatment of Cystic Fibrosis: comparing the case of the G970D and G970R mutation. 129
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays 126
Epigenetic effects of butyrate in children with congenital chloride diarrhea: an in-vivo and in-vitro study. 124
A novel de novo missense mutation in TP63 underlying germline mosaicism in AEC syndrome: Implications for recurrence risk and prenatal diagnosis. 123
TrkB gene expression and DNA methylation state in Wernicke area does not associate with suicidal behavior. 122
MTHFR C677T allelic variant is not associated to plasma and cerebrospinal fluid homocysteine in amyotrophic lateral sclerosis 122
Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study 121
Cystic Fibrosis Patients with F508del/Minimal Function Genotype: Laboratory and Nutritional Evaluations after One Year of Elexacaftor/Tezacaftor/Ivacaftor Treatment 120
Two cases of microvillous inclusion disease caused by novel mutations in MYO5B gene 120
Target Protector PNA: a new tool in Cystic Fibrosis treatment 119
Analisi molecolare della nuova variante allelica T4Gnella regione 4G/5G del promotore del gene PAI-1. 118
Elexacaftor–tezacaftor–ivacaftor therapy for cystic fibrosis patients with the f508del/unknown genotype 118
High-throughput screening identifies FAU protein as a regulator of mutant cystic fibrosis transmembrane conductance regulator channel 117
Molecular analysis of prothrombotic gene variants in patients with acute ischemic stroke and with transient ischemic attack 114
Molecular and functional analysis of the promoter region of CFTR gene in CF and CFTR related disorders patients. 113
The implication of MBL deficient haplotypes in acute coronary syndrome. 113
An Update on Laboratory Diagnosis of Liver Inherited Diseases 112
Two CFTR mutations within codon 970 differently impact on the chloride channel functionality 112
The Immune Response to SARS-CoV-2 Vaccine in a Cohort of Family Pediatricians from Southern Italy 111
Twelve Novel Mutations in the SLC26A3 Gene in 17 Sporadic Cases of Congenital Chloride Diarrhea 110
GENOTYPE PREDICTS THE RESPONSE TO THERAPY IN CHILDREN WITH CONGENITAL CHLORIDE DIARRHEA. 109
Prothrombotic gene variants in acute myocardial infarction at a young age (yAMI). Rationale for tailored prevention strategies in specific risk-group subjects for acute coronary disease? 104
Ricerca di fattori trascrizionali allele specifici per due nuove varianti riscontrate nelle CSTs di CFTR. 103
Identificazionee caratterizzazione di mutazioni in regioni regolatorie del gene malattia della fibrosi cistica 103
Sars-cov-2: One year in the pandemic. What have we learned, the new vaccine era and the threat of sars-cov-2 variants 103
The relevance of prothrombotic genetic variants in women who experienced pregnancy loss or embryo implantation failure: A retrospective analysis of 1922 cases 102
BUTYRATE MODULATES EPITHELIAL DRA EXPRESSION IN CHILDREN WITH CONGENITAL CHLORIDE DIARRHEA 101
Cystic fibrosis, molecular genetics for all life 98
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells 98
A novel polymorphism in the PAI-1 gene promoter enhances gene expression. A novel pro-thrombotic risk factor? 97
Haemophilia A: the consequences of de novo mutations. Two case reports 96
Lung microbiome in cystic fibrosis 95
Patient-derived cell models for personalized medicine approaches in cystic fibrosis 90
Targetable domains for the design of peptide-dendrimer inhibitors of SARS-CoV-2 90
Gene Mutation in MicroRNA Target Sites of CFTR Gene: A Novel Pathogenetic Mechanism in Cystic Fibrosis? 88
The friendly use of chloroquine in the COVID-19 disease: A warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene 81
Effectiveness of elexacaftor/tezacaftor/ivacaftor therapy in three subjects with the cystic fibrosis genotype phe508del/unknown and advanced lung disease 78
Porphyromonas somerae in urinary microbiome and its potential metabolic role in bladder cancer 74
Congenital diarrheal disorders: an updated diagnostic approach 70
Molecular and Functional Analysis of the Large 5' Promoter Region of CFTR Gene Revealed Pathogenic Mutations in CF and CFTR-Related Disorders. 70
The Kelch protein NS1-BP interacts with alpha-enolase/MBP-1 and is involved in c-Myc gene transcriptional control 70
Genotype-dependency of butyrate efficacy in children with congenital chloride diarrhea 68
Evaluation of butyrate efficacy in treatment of congenital chloride diarrhea: from genotype to clinical response. 68
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 66
Ex vivo model predicted in vivo efficacy of CFTR modulator therapy in a child with rare genotype 61
Effect of CFTR Modulators on Oxidative Stress and Autophagy in Non-CFTR-Expressing Cells 54
Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination 47
Editorial Comment to p.Leu636Pro mutation is associated with cystic fibrosis transmembrane conductance regulator-related disorders (congenital bilateral absence of vas deferens) 47
Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients 36
Mouse intestine as a useful model for CFTR electrophysiology function analysis 35
Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in a Cystic Fibrosis Child With L1077P Mutation 32
null 12
Mechanisms of action of butyrate in congenital chloride diarrhea (CLD) 3
Totale 11.784
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.879
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022656 0 27 14 26 7 32 13 37 93 113 127 167
2022/2023782 76 52 31 65 75 74 39 68 105 117 62 18
2023/2024623 29 77 90 43 39 59 36 59 27 32 72 60
2024/20252.844 149 142 20 78 107 178 268 218 145 308 1.008 223
2025/20265.476 559 376 552 637 1.054 250 484 395 568 366 112 123
2026/2027149 119 30 0 0 0 0 0 0 0 0 0 0
Totale 11.784